On Air Now

Current Show

Health Talk   9:00 PM - 10:00 PM

Call in to “Health Talk” with Dr. Ronald Hoffman at 800-544-7070.

Show Info »

Upcoming Shows

Program Schedule »

Tune in to Listen

650 AM Hibbing, Minnesota

Weather

Current Conditions(Hibbing,MN 55746)

More Weather »
62° Feels Like: 62°
Wind: WNW 3 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Thunderstorms Early 55°

Tomorrow

PM Thunderstorms 66°

Sun Night

Thunderstorms 48°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

Tranzyme to explore strategic options

(Reuters) - Drugmaker Tranzyme Inc said it will explore strategic options, including a sale, less than two months after it stopped the second mid-stage trial of its drug for stomach paralysis.

The company retained Stifel as its financial adviser for the strategic review process, and said it has not made a decision to pursue any specific transaction.

Tranzyme went public in April 2011 at $4 per share and has a market value of $15 million. It has two other products in early testing.

Tranzyme shares closed at 56 cents on Thursday on the Nasdaq.

(Reporting by Esha Dey in Bangalore; Editing by Supriya Kurane)

Comments